跳至主要内容
临床试验/CTRI/2017/10/010073
CTRI/2017/10/010073已完成4 期

A randomized controlled trial of rTMS augmentation in depression

Jyoti Singh0 个研究点目标入组 29 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
29

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Diagnosis of depression based on ICD-10 DCR criteria (F32, F33)
  • 2.Age 18-50 years
  • 3.Treated with adequate dose of any antidepressant(s) for at least 4 weeks
  • 4.Clinical Global Impression-Improvement (CGI-I) rating worse than/equal to 3 (as per treating Psychiatrist)
  • 5.Montgomery Asberg Depression Rating Scale (MADRS) score in the range of at least moderate depression (>=20)
  • 6.Written informed consent

排除标准

  • 1.Patients with suicidality
  • 2.Depression with psychotic symptoms
  • 3.Bipolar depression
  • 4.Other co-morbid psychiatric disorder including substance use (except nicotine)
  • 5.Medical co-morbidities requiring priority medical management
  • 6.Presence of contra-indications to rTMS such as metallic implants, seizure disorder etc.
  • 7.Pregnant females and lactating mothers

研究者

发起方
Jyoti Singh

相似试验